Back to Search
Start Over
Monitoring of circulating tumor cells and their expression of EGFR/phospho-EGFR during combined radiotherapy regimens in locally advanced squamous cell carcinoma of the head and neck.
- Source :
-
International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2012 Aug 01; Vol. 83 (5), pp. e685-90. Date of Electronic Publication: 2012 May 12. - Publication Year :
- 2012
-
Abstract
- Purpose: The numbers of circulating tumor cells (CTCs) and their expression/activation of epidermal growth factor receptor (EGFR) during the course of combined chemo- or bioradiotherapy regimens as potential biomarkers of treatment efficacy in squamous cell carcinoma of the head and neck (SCCHN) were determined.<br />Methods and Materials: Peripheral blood samples from SCCHN patients with locally advanced stage IVA/B disease who were treated with concurrent radiochemotherapy or induction chemotherapy followed by bioradiation with cetuximab were included in this study. Using flow cytometry, the absolute number of CTCs per defined blood volume as well as their expression of EGFR and its phosphorylated form (pEGFR) during the course of treatment were assessed.<br />Results: Before treatment, we detected ≥1 CTC per 3.75 mL blood in 9 of 31 patients (29%). Basal expression of EGFR was detected in 100% and pEGFR in 55% of the CTC+ cases. The frequency of CTC detection was not influenced by induction chemotherapy. However, the number of CTC+ samples significantly increased after radiotherapy. This radiation-induced increase in CTC numbers was less pronounced when radiotherapy was combined with cetuximab compared to its combination with cisplatin/5-fluorouracil. The former treatment regimen was also more effective in reducing pEGFR expression in CTCs.<br />Conclusions: Definitive radiotherapy regimens of locally advanced SCCHN can increase the number of CTCs and might thus contribute to a systemic spread of tumor cells. Further studies are needed to evaluate the predictive value of the radiation-induced increase in CTC numbers and the persistent activation of the EGFR signalling pathway in individual CTC+ cases.<br /> (Copyright © 2012 Elsevier Inc. All rights reserved.)
- Subjects :
- Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Carcinoma, Squamous Cell pathology
Cetuximab
Cisplatin administration & dosage
Combined Modality Therapy methods
Female
Flow Cytometry
Fluorouracil administration & dosage
Head and Neck Neoplasms pathology
Humans
Induction Chemotherapy methods
Male
Middle Aged
Neoplastic Cells, Circulating radiation effects
Phosphorylation
Squamous Cell Carcinoma of Head and Neck
Biomarkers, Tumor metabolism
Carcinoma, Squamous Cell metabolism
Carcinoma, Squamous Cell therapy
Chemoradiotherapy methods
ErbB Receptors metabolism
Head and Neck Neoplasms metabolism
Head and Neck Neoplasms therapy
Neoplastic Cells, Circulating metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1879-355X
- Volume :
- 83
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- International journal of radiation oncology, biology, physics
- Publication Type :
- Academic Journal
- Accession number :
- 22583603
- Full Text :
- https://doi.org/10.1016/j.ijrobp.2012.02.009